Ondansetron Hydrochloride
Product Images NDC 68071-2855

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 68071-2855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2855 3)

Pdp (68071 2855 3)
NuCare Pharmaceuticals, Inc. is a manufacturer of Ondansetron, which is a medication that prevents nausea and vomiting caused by cancer chemotherapy and radiation therapy. The medication is available in 8mg tablets with 30 tablets per bottle. The lot number is 00000, and the NDC number is 68071-2855-03. Each film-coated tablet contains Ondansetron hydrochloride USP equivalent to 8mg of Ondansetron. The manufacturer's label expiry date is 00-00. The product should be stored at a controlled temperature of 68-77°F and kept out of reach of children. An Rx is required to purchase Ondansetron, and any side effects should be reported to 1-800-FDA-1088.*
FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.